https://pittplusme.org/study/2163
APD334-205: Alopecia Areata Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Are you 18-70 years old? Do you have alopecia areata (loss of hair in small patches)? You may be able to participate in a study to evaluate how safe and effective an investigational drug called etrasimod is in people with alopecia areata. Compensation is provided.
IRB: SSU00160835
- Arena Pharmaceuticals, Inc. - APD334-205, A multicenter, randomized, double-blind, placebo-controlled, 24-week study, with a 28-week open-label extension, to assess the safety and efficacy of Etrasimod in subjects with moderate-to-severe alopecia areata. (Pro00042018)
AGE:
18-70
DURATION:
Up to 60 weeks
VISITS:
Up to 15 visits
LOCATION:
Falk Medical Building - Oakland
COMPENSATION:
Up to $2950
SHARE STUDY
MEET THE RESEARCHER
Laura Ferris
Laura Korb Ferris, MD, PhD, is Professor of Dermatology at the University of Pittsburgh School of Medicine, and is also the Director of Clinical Trials for the Department of Dermatology. Dr. Ferris earned her doctorate in immunology from Johns Hopkins University and her medical degree from the University of Maryland.